Minnie Jacob

1.6k total citations
28 papers, 1.1k citations indexed

About

Minnie Jacob is a scholar working on Molecular Biology, Clinical Biochemistry and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Minnie Jacob has authored 28 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 13 papers in Clinical Biochemistry and 6 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Minnie Jacob's work include Metabolism and Genetic Disorders (13 papers), Metabolomics and Mass Spectrometry Studies (8 papers) and Neonatal Health and Biochemistry (6 papers). Minnie Jacob is often cited by papers focused on Metabolism and Genetic Disorders (13 papers), Metabolomics and Mass Spectrometry Studies (8 papers) and Neonatal Health and Biochemistry (6 papers). Minnie Jacob collaborates with scholars based in Saudi Arabia, Canada and Australia. Minnie Jacob's co-authors include Anas M. Abdel Rahman, Majed Dasouki, Andreas L. Lopata, Mohamed S. Rashed, Mohamed Al‐Amoudi, Martin P. Bucknall, Pinar T. Ozand, Osama Y. Al-Dirbashi, Hassan Y. Aboul‐Enein and Zuhair N. Al‐Hassnan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Minnie Jacob

28 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Minnie Jacob Saudi Arabia 15 604 286 178 170 110 28 1.1k
Gianfranco Fornasini Australia 12 358 0.6× 315 1.1× 47 0.3× 219 1.3× 102 0.9× 14 872
James D. Shoemaker United States 16 347 0.6× 222 0.8× 39 0.2× 137 0.8× 55 0.5× 34 864
James A. West United Kingdom 18 801 1.3× 103 0.4× 85 0.5× 653 3.8× 45 0.4× 47 1.8k
A. Berteloot Canada 22 627 1.0× 126 0.4× 48 0.3× 123 0.7× 106 1.0× 56 1.4k
Stephen T. Buckley Denmark 19 370 0.6× 151 0.5× 65 0.4× 82 0.5× 66 0.6× 37 1.3k
Rosa Mangerini Italy 15 311 0.5× 84 0.3× 39 0.2× 271 1.6× 135 1.2× 28 970
Michel Hochuli Switzerland 17 976 1.6× 161 0.6× 62 0.3× 481 2.8× 22 0.2× 41 1.8k
Karin A. Zemski Berry United States 18 944 1.6× 64 0.2× 547 3.1× 207 1.2× 49 0.4× 38 1.4k
Ayako Furugen Japan 17 327 0.5× 66 0.2× 46 0.3× 86 0.5× 117 1.1× 90 931
Kristaps Klavins Austria 18 566 0.9× 41 0.1× 144 0.8× 202 1.2× 18 0.2× 44 1.0k

Countries citing papers authored by Minnie Jacob

Since Specialization
Citations

This map shows the geographic impact of Minnie Jacob's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minnie Jacob with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minnie Jacob more than expected).

Fields of papers citing papers by Minnie Jacob

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minnie Jacob. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minnie Jacob. The network helps show where Minnie Jacob may publish in the future.

Co-authorship network of co-authors of Minnie Jacob

This figure shows the co-authorship network connecting the top 25 collaborators of Minnie Jacob. A scholar is included among the top collaborators of Minnie Jacob based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minnie Jacob. Minnie Jacob is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jacob, Minnie, Afshan Masood, & Anas M. Abdel Rahman. (2023). Multi-Omics Profiling in PGM3 and STAT3 Deficiencies: A Tale of Two Patients. International Journal of Molecular Sciences. 24(3). 2406–2406. 2 indexed citations
2.
Dahabiyeh, Lina A., et al.. (2023). Metabolomics profiling distinctively identified end-stage renal disease patients from chronic kidney disease patients. Scientific Reports. 13(1). 6161–6161. 21 indexed citations
3.
Jacob, Minnie, et al.. (2022). Metabolomics Profiling of Nephrotic Syndrome towards Biomarker Discovery. International Journal of Molecular Sciences. 23(20). 12614–12614. 7 indexed citations
4.
Masood, Afshan, Minnie Jacob, Hicham Benabdelkamel, et al.. (2021). Distinctive metabolic profiles between Cystic Fibrosis mutational subclasses and lung function. Metabolomics. 17(1). 4–4. 12 indexed citations
5.
Jacob, Minnie, Afshan Masood, Hamoud Al‐Mousa, et al.. (2021). Proteomics Profiling to Distinguish DOCK8 Deficiency From Atopic Dermatitis. SHILAP Revista de lepidopterología. 2. 774902–774902. 5 indexed citations
6.
Jacob, Minnie, Xian Luo, Hamoud Al‐Mousa, et al.. (2019). Metabolomics Distinguishes DOCK8 Deficiency from Atopic Dermatitis: Towards a Biomarker Discovery. Metabolites. 9(11). 274–274. 19 indexed citations
7.
Alzoubi, Karem H., Minnie Jacob, Goran Matic, et al.. (2018). Metabolomics Based Profiling of Dexamethasone Side Effects in Rats. Frontiers in Pharmacology. 9. 46–46. 73 indexed citations
8.
Jacob, Minnie, Hamoud Al‐Mousa, Andreas L. Lopata, et al.. (2018). Quantitative profiling of cytokines and chemokines in DOCK8‐deficient and atopic dermatitis patients. Allergy. 74(2). 370–379. 12 indexed citations
9.
Jacob, Minnie, et al.. (2018). A targeted metabolomics approach for clinical diagnosis of inborn errors of metabolism. Analytica Chimica Acta. 1025. 141–153. 71 indexed citations
10.
Eissa, Shimaa, et al.. (2018). Development of Impedimetric Immunosensors for the Diagnosis of DOCK8 and STAT3 Related Hyper‐Immunoglobulin E Syndrome. Electroanalysis. 30(9). 2021–2027. 3 indexed citations
11.
Al-Dirbashi, Osama Y., Tomofumi Santa, Mohamed S. Rashed, et al.. (2008). Rapid UPLC-MS/MS method for routine analysis of plasma pristanic, phytanic, and very long chain fatty acid markers of peroxisomal disorders. Journal of Lipid Research. 49(8). 1855–1862. 46 indexed citations
12.
Rashed, Mohamed S., et al.. (2008). Improved method to determine succinylacetone in dried blood spots for diagnosis of tyrosinemia type 1 using UPLC‐MS/MS. Biomedical Chromatography. 22(11). 1181–1185. 30 indexed citations
13.
Al-Dirbashi, Osama Y., et al.. (2006). UPLC-MS/MS determination of doxazosine in human plasma. Analytical and Bioanalytical Chemistry. 385(8). 1439–1443. 36 indexed citations
14.
Aboul‐Enein, Hassan Y., et al.. (2005). Rapid liquid chromatography–tandem mass spectrometry method for quantification of ziprasidone in human plasma. Biomedical Chromatography. 20(4). 365–368. 28 indexed citations
15.
16.
Al-Dirbashi, Osama Y., et al.. (2005). Determination of methylmalonic acid in urine by HPLC with intramolecular excimer‐forming fluorescence derivatization. Biomedical Chromatography. 20(1). 54–60. 13 indexed citations
17.
Al-Dirbashi, Osama Y., Mohamed S. Rashed, H.J. ten Brink, et al.. (2005). Determination of succinylacetone in dried blood spots and liquid urine as a dansylhydrazone by liquid chromatography tandem mass spectrometry. Journal of Chromatography B. 831(1-2). 274–280. 33 indexed citations
18.
Al-Dirbashi, Osama Y., et al.. (2005). Quantification of succinylacetone in urine of hepatorenal tyrosinemia patients by HPLC with fluorescence detection. Clinica Chimica Acta. 365(1-2). 243–248. 13 indexed citations
19.
Rashed, Mohamed S., Amal Saadallah, Zuhair Rahbeeni, et al.. (2004). Determination of urinary S‐sulphocysteine, xanthine and hypoxanthine by liquid chromatography–electrospray tandem mass spectrometry. Biomedical Chromatography. 19(3). 223–230. 34 indexed citations
20.
Al-Dirbashi, Osama Y., et al.. (2004). Diagnosis of Methylmalonic Acidemia from Dried Blood Spots by HPLC and Intramolecular-Excimer Fluorescence Derivatization. Clinical Chemistry. 51(1). 235–237. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gianfranco Fornasini Breakdown of academic impact, for papers by James D. Shoemaker Breakdown of academic impact, for papers by James A. West Breakdown of academic impact, for papers by A. Berteloot Breakdown of academic impact, for papers by Stephen T. Buckley Breakdown of academic impact, for papers by Rosa Mangerini Breakdown of academic impact, for papers by Michel Hochuli Breakdown of academic impact, for papers by Karin A. Zemski Berry Breakdown of academic impact, for papers by Ayako Furugen Breakdown of academic impact, for papers by Kristaps Klavins
Rankless by CCL
2026